Catalin Barbacioru’s 2 research works with 18 citations and reads, including: aan Rare trisomy SuppMaterial Pertile Catalin Barbacioru has. Catalin Barbacioru’s 81 research works with citations and reads, including: ngS1. Catalin Barbacioru has expertise in Biology and Medicine. USPTO patent applications submitted by and patents granted to Catalin Barbacioru.
|Published (Last):||18 October 2007|
|PDF File Size:||9.47 Mb|
|ePub File Size:||7.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
The base level coverage for each base position is normalized to account for the characteristics of the hybridization probes.
Mathematics Genealogy Project
Pharmacokinetic Mapping of Breast Tumors: Cross-contamination is determined by modeling the variant allele frequency for the test sequences as a function of minor allele frequency, contamination level, and background noise. Combinatorial Scientific Computing Parallel short sequence mapping for high throughput genome sequencing.
CanalesYongming A. KeysFrances ChanKaren A. New articles related to this author’s research. The following articles are merged in Scholar. BarbacioruDaniel J. BramlettJeffrey K. Get my own profile Cited by View all All Since Citations h-index 25 19 iindex 27 BarbacioruAnand ArunachalamDaniel J. My profile My library Metrics Alerts.
BarbacioruEiad B. IchikawaFiona C.
dblp: Catalin C. Barbacioru
New citations to this author. Genome biology 12 12R Correlating gene expression with chemical scaffolds of cytotoxic agents: Methods disclosed herein can also be used to diagnose conditions or to support treatment-related decisions.
Sean Walsh, Moraima Pagan. The genes provided by the present teachings define a set of diagnostic markers, thus providing a blood-based gene expression test to facilitate early detection of TAA disease. New articles by this author. In some cases, the variant allele frequency is based on a probability function including the minor allele frequency.
The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from other ILDs. This “Cited by” count includes citations to the following articles in Scholar. Cell stem cell 6 5, JensenStephen C. Bmc Bioinformatics 7 1, Additionally, the methods provide for the determination of a confidence value for a copy number assigned to a sample based on attributes of the sample data.
Molecular bioSystems 7 12, WangRoger D. Trier 1 Trier 2. Negating the test sequences allows more test sequences to be simultaneously analyzed to determine cross-contamination. Cross-contamination of a test sample used to determine cancer is identified using gene sequencing data.
ShiWendell D. Onur Sakarya, Catalin Barbacioru.
In some embodiments, the fragment size parameter is adjusted to remove within-sample GC-content bias. In some embodiments, removal of within-sample GC-content bias is based on sequence data corrected for systematic variation common across unaffected training samples. Gene copy number variations are identified for genes in a targeted gene panel. The present disclosure provides methods for diagnosis of interstitial lung diseases ILDs.
PloS one 2 10e NutterJian GuKelli S.